martes, 4 de abril de 2017

CDC - Continued CDC Funding for States to Detect, Respond, Prevent and Innovate - DPEI - NCEZID

CDC - ELC Cooperative Agreement - DPEI - NCEZID

header image for ELC National Funding Strategy

Continued CDC Funding for States to Detect, Respond, Prevent and Innovate

Through CDC’s Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement, CDC continues to work with state and local health departments to implement tracking, prevention, and antibiotic stewardship activities – transforming how the nation combats and slows antibiotic resistance at all levels.
In addition to investments made last year, CDC is inviting grantees to participate in enhanced activities, potentially including:
  • Whole genome sequencing in all states to determine AR profiles for every Salmonella isolate, and expanding testing for other germs in the future.
  • Enhanced epidemiologic support for foodborne investigations—interviewing more patients faster and in greater detail—to ensure rapid response.
  • Identifying new ways to prevent human infection caused by resistant bacteria in food animals, through NARMS and partnerships with FDA and USDA.
  • Increased testing nationwide for the fungal threat Candida, including C. auris.
  • Using Integrated Food Safety Centers of Excellence to provide instructional materials on antimicrobial resistance for veterinarians.
These activities will enhance capacities to rapidly detect antibiotic resistance and prevent its spread to better protect Americans. Visit CDC’s antibiotic resistance website for the funding announcement.
See how CDC invested in every state in 2016 to combat antibiotic resistance in healthcare facilities, the community, and food.
Local CDC investments through ELC combat antibiotic resistance by strengthening the public health workforce and building stronger surveillance systems, modern and efficient laboratory facilities, and more integrated health information networks.

No hay comentarios: